Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

Targeting Vδ1+T-cells may help treat alopecia areata.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Stat3 influences keratinocyte stem cell behavior, affecting differentiation and migration.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Skin cancer often starts from Lgr5+ progenitor cells.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Skin cells control immune cell placement, helping the skin respond better to challenges.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

Lower SMAD2/3 activation predicts more severe skin cancer.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

Antibodies help identify glycoproteins in normal skin and tumor cells.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Controlling Tslp can improve health in AEC syndrome patients.

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.